[Thioridazine for the treatment of behavior disorders in patients with intellectual disability]
Soto N I, Augustovski F, Pichon-Riviere A, García Martí S, Alcaraz A, Bardach A, Ciapponi A.
Record ID 32018001435
Spanish
Original Title:
Tioridazina para problemas de conducta en pacientes con discapacidad intelectual
Authors' recommendations:
CONCLUSIONS
Evidence on the use of thioridazine for the treatment of challenging behavior in patients with intellectual disability is scarce and of very low quality; therefore, it is not possible to draw conclusions on its effectiveness. On the other hand, there is evidence indicating that the risk of cardiac death associated to the use of this drug is higher than the risk associated to other antipsychotics used for this indication. No studies assessing the financial impact or cost-effectiveness of this intervention have been conducted.
Details
Project Status:
Completed
Year Published:
2018
URL for published report:
https://www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Thioridazine
- Antipsychotic Agents
- Behavior Control
- Intellectual Disability
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.